Radiolabeled Nanogels: From Multimodality Imaging to Combination Therapy of Cancer
Open Access
- 19 June 2025
- journal article
- Published by Wiley in Small Science
- Vol. 5 (8)
Abstract
Advancements in nanotechnology over the past few decades have offered tremendous possibilities toward cancer theranostics. Radiolabeled nanogels (NGs) represent a promising nanoplatform in this direction, offering a multifunctional toolset for both imaging and therapeutic interventions. This review encapsulates the progressions and potential of radiolabeled NGs in the realm of cancer research. Firstly, multifunctional radiolabeled NGs serve as potent contrast agents for multimodality imaging, enabling precise visualization of tumor sites through various techniques such as positron emission tomography, single‐photon emission computed tomography, optical imaging and magnetic resonance imaging. Furthermore, by incorporating more than one therapeutic payload such as chemotherapeutic drugs, nucleic acids, and/or therapeutic radionuclides, they enable synergistic treatment modalities that address the heterogeneity of cancer cells and their microenvironment. This combination approach allows for enhanced therapeutic efficacy while minimizing systemic toxicity, addressing challenges associated with conventional cancer therapies. Furthermore, the radiolabeling of NGs provides a means for real‐time monitoring of therapeutic distribution and pharmacokinetics, offering valuable insights into treatment response and optimization. Overall, radiolabeled NGs represent a promising platform for the integration of multimodality imaging and combination therapy in the fight against cancer with increased efficacy, reduced toxicity, and improved patient outcomes.Keywords
Funding Information
- Department of Atomic Energy, Government of India
- National Institutes of Health (P30 CA014520)
This publication has 254 references indexed in Scilit:
- Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer TherapyAdvanced Materials, 2023
- Exploring the Potential of Nanogels: From Drug Carriers to Radiopharmaceutical AgentsAdvanced Healthcare Materials, 2023
- Protease Responsive Nanogels for Transcytosis across the Blood−Brain Barrier and Intracellular Delivery of Radiopharmaceuticals to Brain Tumor CellsAdvanced Healthcare Materials, 2021
- Effective Intratumoral Retention of [103Pd]AuPd Alloy Nanoparticles Embedded in Gel‐Forming Liquids Paves the Way for New NanobrachytherapyAdvanced Healthcare Materials, 2021
- Prevention and treatment of radiotherapy‐induced side effectsMolecular Oncology, 2020
- Biocompatible Semiconductor Quantum Dots as Cancer Imaging AgentsAdvanced Materials, 2018
- Cancer‐Associated, Stimuli‐Driven, Turn on Theranostics for Multimodality Imaging and TherapyAdvanced Materials, 2017
- Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?Advanced Healthcare Materials, 2017
- Injectable Colloidal Gold in a Sucrose Acetate Isobutyrate Gelating Matrix with Potential Use in Radiation TherapyAdvanced Healthcare Materials, 2014
- A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal AlkynesAngewandte Chemie International Edition, 2002